Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

Clinical trial NCT00329355 · COMPLETED

Trial details

NCT number: NCT00329355
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Migraine Disorders

Start date: 2006-05-01
Primary completion: 2006-11-01
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.